Dexcom (DXCM) is in talks to buy out diabetes device maker Insulet Corp (PODD), according to Bloomberg reports.
Dexcom to acquire Insulet- Diabetic Device
The two companies are currently negotiating the deal and an agreement could be reached over the following weeks.
Dexcom to acquire Insulet- Negotiations
Insulet and Dexcom had market valuations of $14.1 billion and $31.8 billion, respectively.
Dexcom to acquire Insulet- Market Value
Dexcom and Insulet come in the midst of a significant slowdown in dealmaking in the healthcare sector.
Dexcom to acquire Insulet- Healthcare Sector
Healthcare companies have participated in $103 billion worth of deals in 2022, down 45% year-over-year.
Dexcom to acquire Insulet- Healthcare Worth
Dexcom and Insulet already have a partnership through which Insulet’s delivery system integrates into Dexcom’s glucose.
Dexcom to acquire Insulet- System Inegrates
The deal would provide Dexcom with a closed-loop system to diabetes patients both diagnosis and treatment services.
Dexcom to acquire Insulet- Closed Loop System
The Report sent Insulent shares up 10% in pre-market trading Tuesday. Dexcom shares are down over 7% on the other hand.
Dexcom to acquire Insulet- Share Reaction
Swipe up for More Stories related to Tchnology, Gadgets, Finance, & Other Trending News around the Globe.
Dexcom to acquire Insulet- Swipe Up!!!